Pillr Health Secures Investment from Water Street Healthcare Partners
Pillr Health just did what smart operators do when a system gets louder, messier, and more expensive at scale. They leaned into the pressure and built infrastructure instead of theater. Water Street Healthcare Partners stepping in is not speculative capital chasing headlines. It is disciplined money following signal. When a $66B program keeps growing at 24% YoY while oversight tightens and margin expectations rise, the winners are never the loudest. They are the ones that make complexity survivable.
Pillr Health came together in Feb 2025 from RxStrategies, Hudson Headwaters 340B, and RPH Innovations, three groups that understood the 340B program from completely different vantage points and realized fragmentation was the hidden tax. RxStrategies brought the tech spine. Hudson Headwaters brought real-world safety-net execution. RPH Innovations brought operational command. Boca Raton became the meeting point, but the real convergence happened at the workflow level where compliance, revenue, and care collide daily.
Highbridge is where the weight gets carried. Split billing. Mixed-use inventory control. Real-time prescription visibility. Audit readiness without panic. This is not software designed to impress demos. It is built to survive HRSA scrutiny and boardroom questions in the same week. When Sam's Club Pharmacy selected Highbridge as the foundation for its first-ever 340B participation starting Jan 1, 2026, that was not experimentation. National retail does not place $66B-adjacent bets on fragile plumbing.
300+ hospitals and health systems already run through Pillr Health across 20+ states. That matters when contract pharmacy relationships have grown from 42K to more than 229K in under a decade. At that scale, mistakes compound fast. Compliance stops being a checklist and becomes an operating philosophy. Layer in specialty pharmacy and outpatient retail expansion and suddenly Pillr is not a name. It is a structural element.
Leadership shows up in the details. Skip Devanny did not discover 340B late. From Cerner to Talyst to RxStrategies and now Pillr Health, this has been a long build. Clay Callicoat brings PE-grade financial discipline shaped by acquisitions and integrations. Mickey Price carries 30+ years of pharmacy ops credibility. David Wanless keeps the tech honest. Fenton Markevich brings institutional memory and zero tolerance for sloppy execution. This is a team fluent in both margin math and mission pressure.
Water Street Healthcare Partners knows this terrain. Max Mishkin and Patrick Teyro are not buying novelty. They are backing infrastructure that lets providers fund care under shrinking budgets and rising audits. Organic build. Strategic M&A. National reach. Pressure applied with intent.
The $340B landscape is not simplifying. Specialty pharmacy is a $695.4B global engine growing at 7.5% CAGR. Providers are being asked to do more with less while being watched closer than ever. Pillr Health is building the supports that let the system carry that weight longer, quieter, and with fewer fractures. The interesting part is not that this works today. It is how much room there is left to push it tomorrow.